HealthQuill Drugs Stryker to buy Inari for $4.9b to expand neurovascular business
Drugs Medical Pharma

Stryker to buy Inari for $4.9b to expand neurovascular business

US-based medical device maker Stryker Corporation will acquire Inari Medical Inc., for about $4.9 billion to expand the former’s neurovascular business.

Image Credit: Inari Medical Inc.

HQ Team

January 7, 2025: US-based medical device maker Stryker Corporation will acquire Inari Medical Inc., for about $4.9 billion to expand the former’s neurovascular business.

Stryker will buy Inari for $80 a share in cash and following the initial completion of the tender offer, the Michigan-headquartered company will acquire all remaining shares through a second-step merger at the same price, according to a statement.

The transaction is anticipated to close by the end of the first quarter of 2025.

“The acquisition of Inari expands Stryker’s portfolio to provide life-saving solutions to patients who suffer from peripheral vascular diseases,” said Kevin Lobo, Chair and Chief Executive Officer, of Stryker. 

Venous thromboembolism

“These innovations elevate the standard of care for venous thromboembolism patients and will accelerate Stryker’s impact in endovascular procedures.”

Venous thromboembolisma term referring to blood clots in the veins, occurs when a blood clot develops in a deep vein, most commonly in the lower leg, thigh, or pelvis, but can also occur in the arm, according to the Centers for Disease Control and Prevention.

Thrombosis is responsible for one in four deaths worldwide. Thrombosis is the underlying cause of most heart attacks, strokes, and venous thromboembolism, which encompasses deep vein thrombosis and pulmonary embolism. 

Age is a major risk factor for thrombosis and with the ageing of the population, the global burden of cardiovascular disease has increased, according to the American Heart Foundation.

Surge in demand

Stryker makes devices for orthopaedics, neurotechnology and spinal procedures. The annual revenue guidance of the company was raised for 2025 due to growth in medical and surgical devices.

The medical devices market market is predicted to achieve a revenue of $539.10bn by the year 2025. Among the various markets, Cardiology devices stand out as the largest, with an estimated market volume of $78.65bn in the same year, according to Statista.

The industry is expected to witness a steady growth rate of 5.57% annually leading to a projected market volume of $669.70bn by 2029. When considering the global landscape, it becomes evident that the US will take the lead in revenue generation, with an estimated amount of $190.70bn in 2025.

Maintenance market

The global medical equipment maintenance market size is estimated at $59.29 billion in 2025 and is expected to reach $97.54 billion by 2030, at a compounded annual growth rate of 10.47% during the forecast period (2025-2030), according to Mordor Intelligence.

As medical devices play a crucial role in ensuring patient safety and care quality, the demand for medical equipment maintenance has surged. 

These devices, routinely employed for patient scans and diagnoses, necessitate diligent maintenance to mitigate future repair costs. Medical equipment maintenance encompasses scheduled inspections, routine checkups, and proactive repairs.

Exit mobile version